| Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery (NCT04585074) | Severance Hospital | 2020-04-08 |
| A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer (NCT04288089) | Eisai Inc. | 2020-04-01 |
| Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy Surgery (NCT04297007) | Medipol University | 2020-03-23 |
| Shared Decision Making With Breast Cancer Patients (NCT04177628) | Vejle Hospital | 2020-03-04 |
| 3D Printed Bolus in Post-mastectomy Radiotherapy (NCT04685460) | Jiangxi Provincial Cancer Hospital | 2020-03-01 |
| Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ (NCT04722692) | Uppsala University | 2020-03-01 |
| Risk-Based Breast Screening in Young Women (NCT05675085) | Istituto Oncologico Veneto IRCCS | 2020-01-20 |
| Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device (NCT04239105) | Xijing Hospital | 2020-01-01 |
| Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer (NCT06877416) | Sun Yat-sen University | 2020-01-01 |
| Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer (NCT05764941) | The First Affiliated Hospital with Nanjing Medical University | 2020-01-01 |
| Chemotherapy-induced Circadian Rhythm Disruption (NCT04364347) | Seoul National University Hospital | 2019-12-14 |
| CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer (NCT04059003) | Shengjing Hospital | 2019-11-01 |
| Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania (NCT04085510) | Wendie Berg | 2019-10-23 |
| DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast (NCT04052893) | Shengjing Hospital | 2019-10-01 |
| Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy (NCT03709134) | Sunnybrook Health Sciences Centre | 2019-10-01 |
| Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer (NCT04065321) | Shengjing Hospital | 2019-10-01 |
| Tell us Your Food Story (NCT04117438) | Medical College of Wisconsin | 2019-10-01 |
| Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program (NCT03787966) | Universidad de Granada | 2019-09-01 |
| PREMs on PROMs in Breast Disease (PREMs_PROMs) (NCT04718324) | Uppsala University | 2019-09-01 |
| Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 (NCT04109391) | Tanvex BioPharma USA, Inc. | 2019-08-20 |
| Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza) (NCT04119154) | Harvard School of Public Health (HSPH) | 2019-08-01 |
| Health Economy Register (NCT04386629) | Cankado GmbH | 2019-07-05 |
| Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer (NCT04023292) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2019-07-01 |
| Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. (NCT03283384) | Borstkanker Onderzoek Groep | 2019-06-15 |
| Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer (NCT03435380) | Duke University | 2019-05-07 |
| A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer (NCT03705429) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-05-01 |
| Leflunomide in Previously Treated Metastatic Triple Negative Cancers (NCT03709446) | Joseph Sparano | 2019-04-16 |
| Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients (NCT03881384) | First Affiliated Hospital Xi'an Jiaotong University | 2019-04-01 |
| Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients (NCT05326295) | Hunan Cancer Hospital | 2019-03-01 |
| Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c (NCT04488107) | Ahon Pharmaceutical Co., Ltd. | 2019-02-14 |
| Limited Versus No-limited Shoulder Movement in Breast Cancer Surgery (NCT03796845) | Instituto Nacional de Cancer, Brazil | 2019-02-01 |
| Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer (NCT03979911) | University Hospital, Brest | 2019-01-22 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer (NCT03785704) | Peking Union Medical College | 2019-01-01 |
| Adapted Physical Activity (APA) in a Breast Cancer Population. (NCT03528473) | University Of Perugia | 2019-01-01 |
| Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk Factors (NCT04676438) | Moroccan Society of Surgery | 2018-12-10 |
| The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer (NCT03756090) | Zhejiang Cancer Hospital | 2018-12-01 |
| The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread (NCT03659136) | Boehringer Ingelheim | 2018-11-28 |
| Optimized Rehabilitation Following Primary Breast Cancer Surgery (NCT03434717) | Lund University | 2018-11-15 |
| Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer (NCT03477019) | St. Olavs Hospital | 2018-11-12 |
| Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer (NCT03904173) | Oslo University Hospital | 2018-10-29 |
| PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors (NCT03685591) | Pfizer | 2018-10-04 |
| Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer (NCT04603209) | Saint John's Cancer Institute | 2018-10-03 |
| Photobiomodulation for Breast Cancer Radiodermatitis (NCT04059809) | AC Camargo Cancer Center | 2018-09-26 |
| Delphinus SoftVue™ ROC Reader Study (NCT03698942) | Delphinus Medical Technologies, Inc. | 2018-09-23 |
| Abbreviated Breast MRI After Cancer Treatment (NCT03664778) | University of Pennsylvania | 2018-09-07 |
| Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer (NCT02776917) | Barbara Parker, MD | 2018-08-15 |
| Influence of Multidisciplinary Breast Tumor Board on Physician Decision (NCT03596463) | Okan University | 2018-08-13 |
| Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer (NCT03583580) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2018-07-19 |
| Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity (NCT03685175) | University of Texas Southwestern Medical Center | 2018-07-03 |
| Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy Intervention (NCT03389204) | Assuta Medical Center | 2018-07-01 |
| Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer (NCT03594396) | Seoul National University Hospital | 2018-06-29 |
| Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer (NCT03556358) | Tanvex BioPharma USA, Inc. | 2018-06-28 |
| Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients (NCT03742908) | Tianjin Medical University Cancer Institute and Hospital | 2018-06-16 |
| Magnetic Occult Lesion Localization and Imaging (MOLLI) (NCT03660137) | Sunnybrook Health Sciences Centre | 2018-05-28 |
| Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA (NCT05814224) | Centro di Riferimento Oncologico - Aviano | 2018-05-22 |
| A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases (NCT03500380) | RemeGen Co., Ltd. | 2018-04-24 |
| Light-CT in the Diagnosis of Breast Tumor and Lymph Node (NCT03791853) | Peking University People's Hospital | 2018-04-01 |
| GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery (NCT03471494) | University of Edinburgh | 2018-04-01 |
| A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer (NCT03583944) | Eisai Inc. | 2018-03-28 |
| A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01) (NCT03255070) | Ambrx, Inc. | 2018-03-20 |
| PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients (NCT03374826) | Maastricht University Medical Center | 2018-02-22 |
| PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY (NCT03423199) | National Cancer Center, Japan | 2018-02-09 |
| Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy (NCT03393741) | University of Wisconsin, Madison | 2018-01-29 |
| Angiomammography and Neoadjuvant Chemotherapy (NCT05402930) | CHU de Quebec-Universite Laval | 2018-01-03 |
| Lifestyle, Exercise, and Nutrition Study Early After Diagnosis (NCT03314688) | Yale University | 2018-01-02 |
| Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer. (NCT04343079) | University Hospital, Ghent | 2018-01-01 |
| The Tomosynthesis Trial in Bergen - Part 2 (NCT03669926) | Norwegian Institute of Public Health | 2018-01-01 |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer (NCT03280563) | Hoffmann-La Roche | 2017-12-22 |
| Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast (NCT03304080) | Icahn School of Medicine at Mount Sinai | 2017-12-20 |
| The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADS (NCT03791840) | Peking University People's Hospital | 2017-12-01 |
| Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine (NCT03025711) | BELEN RUIZ-ANTORAN | 2017-12-01 |
| A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors (NCT03343054) | Pfizer | 2017-11-30 |
| Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer (NCT03379428) | US Oncology Research | 2017-11-29 |
| Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions (NCT02959398) | Assistance Publique - Hôpitaux de Paris | 2017-11-20 |
| A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer (NCT02898727) | Trans Tasman Radiation Oncology Group | 2017-11-20 |
| A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer (NCT04528225) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2017-11-15 |
| Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen (NCT02819921) | Seoul National University Hospital | 2017-11-10 |
| Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer (NCT03242551) | Shenzhen People's Hospital | 2017-11-08 |
| Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer (NCT03277898) | University of British Columbia | 2017-11-01 |
| PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors (NCT03284723) | Pfizer | 2017-11-01 |
| Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients (NCT03272477) | Palleos Healthcare GmbH | 2017-10-05 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Experimental Study About Physiotherapy Treatment vs Self-treatment In Axillary Web Syndrome After Axillary Dissection (NCT04990960) | Ospedale "Carlo Poma" - Mantova | 2017-10-01 |
| Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions (NCT03280719) | University Hospital, Ghent | 2017-09-15 |
| The Breast Surgery EnLight and LightPath Imaging System Study (NCT02151071) | Lightpoint Medical Limited | 2017-09-01 |
| Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer (NCT03250676) | Eisai Inc. | 2017-08-23 |
| Combined Intra-articular Shoulder Injection and Stellate Ganglion Block in Chronic Post-mastectomy Shoulder Pain (NCT03586154) | Mansoura University | 2017-08-01 |
| Delphinus SoftVue Prospective Case Collection - ARM 1 (NCT03257839) | Delphinus Medical Technologies, Inc. | 2017-07-31 |
| Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients (NCT03762642) | King Abdulaziz University | 2017-07-17 |
| The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer (NCT03202862) | Fudan University | 2017-07-01 |
| Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis (NCT03814811) | Seoul National University Hospital | 2017-07-01 |
| The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy. (NCT02942615) | Ruijin Hospital | 2017-06-27 |
| Effects on the Personalized Rehabilitation Service in Patients With Cancer (NCT03200067) | Seoul National University Bundang Hospital | 2017-06-03 |
| Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer (NCT02718144) | Pantarhei Oncology B.V. | 2017-06-01 |
| A Study of AK-01 (LY3295668) in Solid Tumors (NCT03092934) | Eli Lilly and Company | 2017-05-29 |
| This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer (NCT03099174) | Boehringer Ingelheim | 2017-05-04 |
| Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR (NCT02720185) | University of Wisconsin, Madison | 2017-05-03 |
| The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort Study (NCT03105570) | Peking University People's Hospital | 2017-05-01 |
| Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes (NCT03130946) | Peking University People's Hospital | 2017-05-01 |